Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Articles
Novel Oral Anticoagulants Reduce Total Medical Costs in Patients with Nonvalvular Atrial Fibrillation
Read More
AVERROES: Cost Comparison of Apixaban versus Aspirin
Read More
Conference Highlights AMCP
Electronic Service Alerts Providers of Low-Cost Drugs, Shows Significant Cost-Savings
Read More
Conference Highlights AMCP
Consumer-Directed Health Plans’ Impact on Medication Adherence in Chronic Conditions
Read More
Conference Highlights AMCP
High-Deductible Health Plans: Mixed Results in Clinical Outcomes, Associated Costs
Read More
Conference Highlights AMCP
Pharmacists’ Knowledge Gap about Oncology Genetic Testing, Benefit Design
Read More
Conference Highlights AMCP
Comparing Cost-Effectiveness of First-Line Therapies for Advanced NSCLC
Read More
Business
Recent Developments, Utilization, and Spending Trends for Pompe Disease Therapies
Stakeholder Perspective
Beyond “Patient Amusement”: New Treatments and Genetic Disease
Read More
Business
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Stakeholder Perspective
Warfarin Utilization in Medicare Patients with Nonvalvular Atrial Fibrillation: Sentinel Data from an Administrative Claims Database
Read More
Editorial
“SCOTUS”: Will They or Won’t They?
Read More
204
205
206
207
208
209
210
Page 207 of 246
Results 2061 - 2070 of 2457